Literatur
- 1
Boomsma M M, Stegeman C A, van der Leij M J, Oost W, Hermans J, Kallenberg C G, Limburg P C,
Cohen T ervaert JW.
Prediction of relapses in Wegener’s granulomatosis by measurement of antineutrophil
cytoplasmic antibody levels: a prospective study.
Arthritis Rheum.
2000;
43
2025-2033
- 2
Both M, Reinhold-Keller E, Müller-Hülsbeck S, Biederer J, Gross W, Heller M, Reuter M.
Entzündliches Aortenbogensyndrom: Stenosediagnostik mittels kontrastverstärkter
3D-MR-Angiographie im Vergleich mit der DSA.
Fortschr Röntgenstr.
2003;
175
1-8
- 3
Brodmann M, Lipp R W, Passath A, Seinost G, Pabst E, Pilger E.
The role of 2 - 18F-fluoro-2-deoxy-D-glucose positron emission tomography
in the diagnosis of giant cell arteritis of the temporal arteries.
Rheumatology.
2003;
16
16
- 4
Brouet J, Clauvel J, Danon F, Klein M, Seligmann M.
Biologic and clinical significance of cryoglobulins. A report of 86 cases.
Am J Med.
1974;
57
775-778
- 5
Choi H K, Lamprecht P, Niles J L, Gross W L, Merkel P A.
Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic
antibodies and proteinase 3 antibodies.
Arthritis Rheum.
2000;
43
226-231
- 6
Cohen Tervaert J W.
ANCA testing in monitoring the activity of the disease.
Kidney Blood Press Res.
2003;
26
226-230
- 7
Csernok E, Ahlquist D, Ullrich S, Gross W L.
A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic
antibodies directed against proteinase 3 and myeloperoxidase in Wegener’s granulomatosis
and microscopic polyangiitis.
Rheumatology (Oxford).
2002;
41
1313-1317
- 8
Csernok E, Holle J.
Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies
against proteinase-3 in Wegener’s granulomatosis: First results from a multicenter
study.
Rheumatology.
2004;
43
174-180
- 9
de Groot K, Schmidt D K, Arlt A C, Gross W L, Reinhold-Keller E.
Standardized neurologic evaluations of 128 patients with Wegener granulomatosis.
Arch Neurol.
2001;
58
1215-1221
- 10
Del Rosso A, Generini S, Pignone A, Matucci-Cerinic M.
Vasculitides secondary to systemic diseases.
Clin Dermatol.
1999;
17
533-547
- 11
Gerber O, Roque C, Coyle P K.
Vasculitis owing to infection.
Neurol Clin.
1997;
15
903-925
- 12
Gross W, Schmitt W, Csernok E.
ANCA and associated diseases. Immunodiagnostic and pathogenetic aspects.
Clin Exp Immunol.
2001;
1993
1-2
- 13
Gross W L, Trabandt A, Reinhold-Keller E.
Diagnosis and evaluation of vasculitis.
J Rheumatol.
2000;
39
245-252
- 14
Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, Noel L, Trepo C.
Polyarteriitis nodosa related to hepatitis B virus. A prospective study with
long-term observation of 41 patients.
Medicine.
1995;
74
238-253
- 15
Hellmich B, Csernok E, Gross W.
20 Years with ANCA (antineutrophil cytoplasmic antibodies): from seromarker
to major pathogenic player in vasculitis.
J Leukoc Biol.
2003;
74
1-2
- 16
Hellmich B, Ehlers S, Csernok E, Gross W L.
Update on the pathogenesis of Churg-Strauss syndrome.
Clin Exp Rheumatol.
2003;
21
S69-77
- 17
Hellmich B, Ehren M, Lindstaedt M, Meyer M, Pfohl M, Schatz H.
Anti-MPO-ANCA-positive microscopic polyangiitis following subacute bacterial
endocarditis.
Clin Rheumatol.
2001;
20
441-443
- 18
Hoffman G S.
Classification of the systemic vasculitides.
Clin Exp Rheumatol.
1998;
16
111-115
- 19
Holl-Ulrich K, Reinhold-Keller E, Muller A, Feller A C.
Pathology of vasculitis: differential diagnosis and selected disorders.
Verh Dtsch Ges Pathol.
2002;
86
83-90
- 20
Jennette J, Andrassy K, Bacon P A, Churg J, Gross W L, Hagen E C, Hoffman G S, Hunder G G,
Kallenberg C GM, McCluskey R T, Sinico R A, Rees A J, van Es L, Waldherr R, Wiik A.
Nomenclature of systemic vasculitides. Proposal of an international consensus
conference.
Arthritis Rheum.
1994;
37
187-192
- 21
Lamprecht P, Gause A, Gross W.
Cryoglobulinemic vasculitis.
Arthritis Rheum.
1999;
42
2507-2516
- 22
Lamprecht P, Moosig F, Gause A, Herlyn K, Csernok E, Hansen H, Gross W.
Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic
vasculitis.
Ann Rheum Dis.
2001;
60
385-390
- 23
Lamprecht P, Moosig F, Gause A, Herlyn K, Gross W L.
Birmingham vasculitis activity score, disease extent index and complement factor
C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic
vasculitis.
Clin Exp Rheumatol.
2000;
18
319-325
- 24
Leavitt R, Fauci A, Bloch D, Michel B, Hunder G, Arend W, Calabrese L, Fries J, Lie J,
Lightfood R J, asi A, cShane D, ills J, tevens M, allace S, vaifler N.
The American College of Rheumatology 1990 criteria for the classification of
Wegener’s granulomatosis.
Arthritis Rheum.
1990;
33
1101-1107
- 25
Matsunaga N, Hayashi K, Sakamoto I, Matsuoka Y, Ogawa Y, Honjo K, Takano K.
Takayasu arteritis: MR manifestations and diagnosis of acute and chronic phase.
J Magn Reson Imaging.
1998;
8
406-414
- 26
Meyer M F, Hellmich B, Kotterba S, Schatz H.
Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent
or opportunistic infection?.
Rheumatol Int.
2000;
20
35-38
- 27
Muhle C, Reinhold-Keller E, Richter C, Duncker G, Beigel A, Brinkmann G, Gross W L,
Heller M.
MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener’s granulomatosis.
Eur Radiol.
1997;
7
566-570
- 28
Nolle B.
Ophthalmological diagnosis in systemic vasculitis.
Z Rheumatol.
2001;
60
226-242
- 29
Paulsen J I, Rudert H.
Manifestations of primary vasculitis in the ENT region.
Z Rheumatol.
2001;
60
219-225
- 30
Rao J, Allen N, Pincus N.
Limitations of the 1990 American College of Rheumatology classification criteria
in the diagnosis of vasculitis.
Ann Intern Med.
1998;
129
345-352
- 31
Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, Heller M, Gross W L.
An interdisciplinary approach to the care of patients with Wegener’s granulomatosis:
long-term outcome in 155 patients.
Arthritis Rheum.
2000;
43
1021-1032
- 32
Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter H H, Raspe H H, Gross W L.
Giant cell arteritis is more prevalent in urban than in rural populations: results
of an epidemiological study of primary systemic vasculitides in Germany.
Rheumatology (Oxford).
2000;
39
1396-1402
- 33
Reuter M, Biederer J, Both M, Schnabel A, Reinhold-Keller E, Gross W L, Heller M.
Radiology of the primary systemic vasculitides.
Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr.
2003;
175
1184-1192
- 34
Reuter M, Schnabel A, Wesner F, Tetzlaff K, Risheng Y, Gross W L, Heller M.
Pulmonary Wegener’s granulomatosis: correlation between high-resolution CT findings
and clinical scoring of disease activity.
Chest.
1998;
114
500-506
- 35
Schmidt W A, Kraft H E, Vorpahl K, Volker L, Gromnica-Ihle E J.
Color duplex ultrasonography in the diagnosis of temporal arteritis.
N Engl J Med.
1997;
337
1336-1342
- 36
Schnabel A, Reuter M, Gloeckner K, Muller-Quernheim J, Gross W L.
Bronchoalveolar lavage cell profiles in Wegener’s granulomatosis.
Respir Med.
1999;
93
498-506
- 37
Schonermarck U, Lamprecht P, Csernok E, Gross W L.
Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil
cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.
Rheumatology (Oxford).
2001;
40
178-184
- 38
Sorensen S, Slot O, Tvede N, Petersen J.
A prospective study of vasculitis patients collected in a five year period:
evaluation of the Chapel Hill nomenclature.
Ann Rheum Dis.
2000;
59
478-482
Priv.-Doz. Dr. med. Bernhard Hellmich
Poliklinik für Rheumatologie, Universitätsklinikum Schleswig-Holstein, Campus
Lübeck
Ratzeburger Allee 160
23538 Lübeck
Phone: +49/451/5002368
Fax: +49/451/5003650
Email: bernhard.hellmich@rheuma.uni-luebeck.de
